These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3918858)

  • 41. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.
    Sakata Y; Curriden S; Lawrence D; Griffin JH; Loskutoff DJ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1121-5. PubMed ID: 3871946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal growth factor stimulates tissue plasminogen activator activity and messenger ribonucleic acid levels in cultured rat granulosa cells: mediation by pathways independent of protein kinases-A and -C.
    Galway AB; Oikawa M; Ny T; Hsueh AJ
    Endocrinology; 1989 Jul; 125(1):126-35. PubMed ID: 2544397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells.
    Van Hinsbergh VW; Sprengers ED; Kooistra T
    Thromb Haemost; 1987 Apr; 57(2):148-53. PubMed ID: 3496679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Secretion of plasminogen activator inhibitor by cultured human epidermal cells.
    Hashimoto K; Nishioka K; Katayama I; Yoshikawa K
    Br J Dermatol; 1986 Aug; 115(2):133-8. PubMed ID: 3091060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
    Bachmann F
    Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relaxin increases the release of plasminogen activator, collagenase, and proteoglycanase from rat granulosa cells in vitro.
    Too CK; Bryant-Greenwood GD; Greenwood FC
    Endocrinology; 1984 Sep; 115(3):1043-50. PubMed ID: 6086281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasminogen activation and regulation of pericellular proteolysis.
    Saksela O
    Biochim Biophys Acta; 1985 Nov; 823(1):35-65. PubMed ID: 2413894
    [No Abstract]   [Full Text] [Related]  

  • 50. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA; Kristensen P; Lund LR; Danø K
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Priming procedure and hormone preparations influence rat granulosa cell response.
    Liu WK; Bousfield GR; Moore WT; Ward DN
    Endocrinology; 1985 Apr; 116(4):1454-9. PubMed ID: 3918855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.
    Erickson LA; Ginsberg MH; Loskutoff DJ
    J Clin Invest; 1984 Oct; 74(4):1465-72. PubMed ID: 6434594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.
    Kruithof EK; Tran-Thang C; Ransijn A; Bachmann F
    Blood; 1984 Oct; 64(4):907-13. PubMed ID: 6434006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasminogen activator secreted by cultured human melanocytes.
    Hashimoto K; Horikoshi T; Nishioka K; Yoshikawa K; Carter DM
    Br J Dermatol; 1986 Aug; 115(2):205-9. PubMed ID: 3091061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasminogen activator (PA) in Guerin epithelioma. Additional PA inhibitor in plasma of rats bearing the epithelioma.
    Tomasiuk R; Mirowski M; Wierzbicki R
    Neoplasma; 1990; 37(5):511-9. PubMed ID: 2146518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An inhibitor of plasminogen activator produced by tumour cell fusion hybrids.
    Badenoch-Jones P; Ramshaw IA; Grant A
    Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():343-52. PubMed ID: 2933023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decreases blood fibrinolytic activity in the rat.
    Dosne AM; Dubor F; Lutcher F; Parant M; Chedid L
    Thromb Res Suppl; 1988; 8():115-22. PubMed ID: 3144762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dexamethasone induction of an inhibitor of plasminogen activator in HTC hepatoma cells.
    Cwikel BJ; Barouski-Miller PA; Coleman PL; Gelehrter TD
    J Biol Chem; 1984 Jun; 259(11):6847-51. PubMed ID: 6427225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction in pO2 decreases the fibrinolytic potential of cultured bovine endothelial cells derived from pulmonary arteries and lung microvasculature.
    Wojta J; Jones RL; Binder BR; Hoover RL
    Blood; 1988 Jun; 71(6):1703-6. PubMed ID: 3259442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.